|
FAM161B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.49609230454462E-13 |
| Normal-vs-Stage2 |
9.78619962843652E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
1.082210E-01 |
| Stage1-vs-Stage3 |
2.18759999999207E-05 |
| Stage1-vs-Stage4 |
3.56590000000212E-05 |
| Stage2-vs-Stage3 |
1.568750E-01 |
| Stage2-vs-Stage4 |
9.165700E-02 |
| Stage3-vs-Stage4 |
6.635200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
2.24720000385759E-08 |
| Normal-vs-Asian |
1.993630E-02 |
| Caucasian-vs-AfricanAmerican |
9.677000E-01 |
| Caucasian-vs-Asian |
2.534000E-01 |
| AfricanAmerican-vs-Asian |
3.492800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.93098878501041E-14 |
| Male-vs-Female |
4.130100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.29449999997089E-06 |
| Normal-vs-Age(41-60Yrs) |
2.33146835171283E-15 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.744360E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.561000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.502800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.909600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.072200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.251000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.983600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.523400E-01 |
| Normal-vs-Grade 2 |
2.10986783599765E-12 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
3.386600E-04 |
| Grade 1-vs-Grade 3 |
1.42650000001243E-06 |
| Grade 1-vs-Grade 4 |
1.97328999999025E-05 |
| Grade 2-vs-Grade 3 |
7.600800E-04 |
| Grade 2-vs-Grade 4 |
1.3328227410625E-12 |
| Grade 3-vs-Grade 4 |
2.41469999999744E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.57840029514045E-10 |
| Normal-vs-ccB subtype |
1.62447832963153E-12 |
| ccA subtype-vs-ccB subtype |
5.291300730903E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
3.02813329966511E-12 |
| N0-vs-N1 |
1.741540E-02 |
|
|
